{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:08:53Z","timestamp":1790096933784,"version":"4.0.1"},"reference-count":102,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.drudis.2026.104768","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:36:57Z","timestamp":1786549017000},"page":"104768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outer membrane as a drug target for the treatment of GNB infections"],"prefix":"10.1016","volume":"31","author":[{"given":"Urjoshi","family":"Chattoraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepanshi","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8823-6074","authenticated-orcid":false,"given":"Sidharth","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104768_b0005","unstructured":"Antibiotic resistance threats in the United States, 2013 Corporate Authors(s): Centers for Disease Control and Prevention (U.S.); National Center for Emerging Zoonotic and Infectious Diseases (U.S.); National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.); National Center for Immunization and Respiratory Diseases (U.S.); Published Date: 2013\/01\/01 URL: https:\/\/stacks.cdc.gov\/view\/cdc\/20705."},{"key":"10.1016\/j.drudis.2026.104768_b0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s44259-023-00016-1","article-title":"Tackling the outer membrane: facilitating compound entry into Gram-negative bacterial pathogens","volume":"1","author":"Saxena","year":"2023","journal-title":"Npj Antimicrob Resist"},{"key":"10.1016\/j.drudis.2026.104768_b0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.biochem.71.110601.135414","article-title":"Lipopolysaccharide endotoxins","volume":"71","author":"Raetz","year":"2002","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.drudis.2026.104768_b0020","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3390\/antibiotics12111590","article-title":"Evaluation of antibiotic resistance mechanisms in Gram-negative bacteria","volume":"12","author":"Gauba","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.drudis.2026.104768_b0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.14134","article-title":"Permeability barriers of Gram-negative pathogens","volume":"1459","author":"Zgurskaya","year":"2020","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.drudis.2026.104768_b0030","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3390\/ph15040476","article-title":"\u03b2-Lactam antibiotics and \u03b2-lactamase enzymes inhibitors, part 2: our limited resources","volume":"15","author":"Alfei","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.drudis.2026.104768_b0035","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","article-title":"Mechanisms of antibiotic resistance","volume":"4","author":"Munita","year":"2016","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.drudis.2026.104768_b0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.22207\/JPAM.18.1.53","article-title":"Antimicrobial resistance: techniques to fight AMR in bacteria\u2014a review","volume":"18","author":"Mahizhchi","year":"2024","journal-title":"J Pure Appl Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0045","unstructured":"Centers for Disease Control and Prevention. Additional action is critical: AR threats and the future of CDC AR threats reporting. CDC Report on Antimicrobial Resistance. June, 2025. https:\/\/www.cdc.gov\/antimicrobial-resistance."},{"key":"10.1016\/j.drudis.2026.104768_b0050","unstructured":"Annual Report. Antimicrobial resistance surveillance and control program. 2024;1:1\u201310."},{"key":"10.1016\/j.drudis.2026.104768_b0055","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2015.0023","article-title":"Outer membrane protein biogenesis in Gram-negative bacteria","volume":"370","author":"Rollauer","year":"2015","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"10.1016\/j.drudis.2026.104768_b0060","doi-asserted-by":"crossref","first-page":"17981","DOI":"10.1074\/jbc.R117.802512","article-title":"The lipopolysaccharide transport (Lpt) machinery: a nonconventional transporter for lipopolysaccharide assembly at the outer membrane of Gram-negative bacteria","volume":"292","author":"Sperandeo","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104768_b0065","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1146\/annurev-micro-090816-093754","article-title":"Outer membrane biogenesis","volume":"71","author":"Konovalova","year":"2017","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrmicro1322","article-title":"Advances in understanding bacterial outer-membrane biogenesis","volume":"4","author":"Ruiz","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0075","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1128\/jb.119.3.1039-1056.1974","article-title":"Electron microscope study of septum formation in Escherichia coli strains B and B\/r during synchronous growth","volume":"119","author":"Burdett","year":"1974","journal-title":"J Bacteriol"},{"key":"10.1016\/j.drudis.2026.104768_b0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fchem.2019.00045","article-title":"Folded synthetic peptides and other molecules targeting outer membrane protein complexes in Gram-negative bacteria","volume":"7","author":"Robinson","year":"2019","journal-title":"Front Chem"},{"key":"10.1016\/j.drudis.2026.104768_b0085","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1182749","article-title":"Peptidomimetic antibiotics target outer-membrane biogenesis in P. aeruginosa","volume":"327","author":"Srinivas","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.drudis.2026.104768_b0090","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-024-07502-0","article-title":"A Gram-negative-selective antibiotic that spares the gut microbiome","volume":"630","author":"Mu\u00f1oz","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104768_b0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41586-021-03455-w","article-title":"The antibiotic darobactin mimics a \u03b2-strand to inhibit outer membrane insertase","volume":"593","author":"Kaur","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104768_b0100","article-title":"Antibiotics that kill Gram-negative bacteria by restructuring the outer membrane protein BamA","author":"Modaresi","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.drudis.2026.104768_b0105","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.aad3747","article-title":"Structural basis of lipoprotein signal peptidase II action and inhibition by the antibiotic globomycin","volume":"351","author":"Vogeley","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.drudis.2026.104768_b0110","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/AAC.06148-11","article-title":"Myxobacterium-produced antibiotic TA (myxovirescin) inhibits type II signal peptidase","volume":"56","author":"Xiao","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.drudis.2026.104768_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115326","article-title":"Small molecule LpxC inhibitors against Gram-negative bacteria: advances and future perspectives","volume":"253","author":"Niu","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2026.104768_b0120","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1021\/jm2014875","article-title":"Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious Gram-negative infections","volume":"55","author":"Montgomery","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2026.104768_b0125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.02223-16","article-title":"In vitro and in vivo efficacy of an LpxC inhibitor, CHIR-090, alone or combined with colistin against P. aeruginosa biofilm","volume":"61","author":"Tan","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.drudis.2026.104768_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115964","article-title":"Lead optimization of 2-hydroxymethyl imidazoles as non-hydroxamate LpxC inhibitors: discovery of TP0586532","volume":"30","author":"Ushiyama","year":"2021","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.drudis.2026.104768_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1541379","article-title":"Recent advances in small molecule LpxC inhibitors against Gram-negative bacteria (2014-2024)","volume":"16","author":"Ji","year":"2025","journal-title":"Front Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0140","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01295-24","article-title":"Evaluation of a potent LpxC inhibitor for post-exposure prophylaxis treatment of antibiotic-resistant Burkholderia pseudomallei in a murine infection model","volume":"69","author":"Heine","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.drudis.2026.104768_b0145","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1039\/D2MD00465H","article-title":"Siderophore conjugates to combat antibiotic-resistant bacteria","volume":"14","author":"Rayner","year":"2023","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.drudis.2026.104768_b0150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrmicro.2016.25","article-title":"Lipopolysaccharide transport and assembly at the outer membrane: the PEZ model","volume":"14","author":"Okuda","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0155","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1473-3099(14)70850-3","article-title":"Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus","volume":"15","author":"Nation","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.drudis.2026.104768_b0160","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41586-018-0083-5","article-title":"Structural basis for dual-mode inhibition of the ABC transporter MsbA","volume":"557","author":"Ho","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104768_b0165","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1463316","article-title":"Lipoprotein transport system Lol may be a selective target for Gram-negative bacteria","volume":"14","author":"Yang","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0170","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00695-23","article-title":"SMT-738: a novel small-molecule inhibitor of bacterial lipoprotein transport targeting Enterobacteriaceae","volume":"68","author":"Breidenstein","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.drudis.2026.104768_b0175","doi-asserted-by":"crossref","first-page":"E6614","DOI":"10.1073\/pnas.1806107115","article-title":"Inhibitor of intramembrane protease RseP blocks the \u03c3E response causing lethal accumulation of unfolded outer membrane proteins","volume":"115","author":"Konovalova","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.drudis.2026.104768_b0180","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbapap.2008.11.005","article-title":"Outer membrane permeability and antibiotic resistance","volume":"1794","author":"Delcour","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.drudis.2026.104768_b0185","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3390\/ijms20071781","article-title":"Two component regulatory systems and antibiotic resistance in Gram-negative pathogens","volume":"20","author":"Bhagirath","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104768_b0190","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nrmicro1994","article-title":"The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria","volume":"6","author":"Pag\u00e8s","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0195","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlab103","article-title":"Resistance mechanisms and genetic relatedness among carbapenem-resistant P. aeruginosa isolates from three major hospitals in Hanoi, Vietnam (2011\u201315)","volume":"3","author":"Tran","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.drudis.2026.104768_b0200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/AAC.45.1.105-116.2001","article-title":"Identification and characterization of inhibitors of multidrug resistance efflux pumps in P. aeruginosa: novel agents for combination therapy","volume":"45","author":"Lomovskaya","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.drudis.2026.104768_b0205","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12300","article-title":"Structural basis for the inhibition of bacterial multidrug exporters","volume":"500","author":"Nakashima","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104768_b0210","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.tim.2015.01.010","article-title":"Assembly and operation of bacterial tripartite multidrug efflux pumps","volume":"23","author":"Du","year":"2015","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0215","doi-asserted-by":"crossref","first-page":"16696","DOI":"10.1073\/pnas.1210093109","article-title":"Conserved small protein associates with the multidrug efflux pump AcrB and differentially affects antibiotic resistance","volume":"109","author":"Hobbs","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.drudis.2026.104768_b0220","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2217\/fmb.14.66","article-title":"Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance","volume":"9","author":"Blair","year":"2014","journal-title":"Fut Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0225","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1128\/JB.181.16.4725-4733.1999","article-title":"Structures of Gram-negative cell walls and their derived membrane vesicles","volume":"181","author":"Beveridge","year":"1999","journal-title":"J Bacteriol"},{"key":"10.1016\/j.drudis.2026.104768_b0230","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0005-2736(76)90058-4","article-title":"Release of outer membrane fragments from normally growing Escherichia coli","volume":"455","author":"Hoekstra","year":"1976","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.drudis.2026.104768_b0235","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1471-2180-9-220","article-title":"Outer membrane vesicle-mediated release of cytolethal distending toxin (CDT) from Campylobacter jejuni","volume":"9","author":"Lindmark","year":"2009","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005672","article-title":"A novel mechanism of host-pathogen interaction through sRNA in bacterial outer membrane vesicles","volume":"12","author":"Koeppen","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.drudis.2026.104768_b0245","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.cell.2016.04.015","article-title":"Bacterial outer membrane vesicles mediate cytosolic localization of LPS and caspase-11 activation","volume":"165","author":"Vanaja","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104768_b0250","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41579-018-0112-2","article-title":"Types and origins of bacterial membrane vesicles","volume":"17","author":"Toyofuku","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0255","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1099\/mic.0.060343-0","article-title":"Predatory activity of Myxococcus xanthus outer-membrane vesicles and properties of their hydrolase cargo","volume":"158","author":"Evans","year":"2012","journal-title":"Microbiology (Reading)"},{"key":"10.1016\/j.drudis.2026.104768_b0260","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1099\/13500872-145-8-2051","article-title":"Membrane vesicles derived from P. aeruginosa and Shigella flexneri can be integrated into the surfaces of other Gram-negative bacteria","volume":"145","author":"Kadurugamuwa","year":"1999","journal-title":"Microbiology (Reading)"},{"key":"10.1016\/j.drudis.2026.104768_b0265","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.01353-18","article-title":"Vesicular delivery of the antifungal antibiotics of Lysobacter enzymogenes C3","volume":"84","author":"Meers","year":"2018","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0270","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.micro.091208.073413","article-title":"Biological functions and biogenesis of secreted bacterial outer membrane vesicles","volume":"64","author":"Kulp","year":"2010","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0275","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrmicro3525","article-title":"Kuehn MJ Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions","volume":"13","author":"Schwechheimer","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0280","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jmb.2008.03.076","article-title":"Engineered bacterial outer membrane vesicles with enhanced functionality","volume":"380","author":"Kim","year":"2008","journal-title":"J Mol Biol"},{"key":"10.1016\/j.drudis.2026.104768_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.bej.2024.109418","article-title":"Evaluation of the efficiency of various methods to load fluoroquinolones into Escherichia coli outer membrane vesicles as a novel antibiotic delivery platform","volume":"210","author":"Wu","year":"2024","journal-title":"Biochem Eng J"},{"key":"10.1016\/j.drudis.2026.104768_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113702","article-title":"Pathogen-targeting biomineralized bacterial outer membrane vesicles for eradicating both intracellular and extracellular S. aureus","volume":"382","author":"Yang","year":"2025","journal-title":"J Control Release"},{"key":"10.1016\/j.drudis.2026.104768_b0295","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12941-024-00734-y","article-title":"Proteomic analysis of carbapenem-resistant Klebsiella pneumoniae outer membrane vesicles under the action of phages combined with tigecycline","volume":"23","author":"Mao","year":"2024","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.drudis.2026.104768_b0300","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.733064","article-title":"Bacterial outer membrane vesicles as antibiotic delivery vehicles","volume":"12","author":"Collins","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2026.104768_b0305","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1021\/nn405724x","article-title":"Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy","volume":"8","author":"Gujrati","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.drudis.2026.104768_b0310","doi-asserted-by":"crossref","first-page":"24866","DOI":"10.1038\/srep24866","article-title":"Protecting enzymatic function through directed packaging into bacterial outer membrane vesicles","volume":"6","author":"Alves","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2026.104768_b0315","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3389\/fmicb.2017.01053","article-title":"Outer membrane vesicles (OMVs) of Gram-negative bacteria: a perspective update","volume":"8","author":"Jan","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0320","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-019-1791-1","article-title":"A new antibiotic selectively kills Gram-negative pathogens","volume":"576","author":"Imai","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104768_b0325","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1348-0421.2007.tb03906.x","article-title":"A new screening method to identify inhibitors of the Lol (localization of lipoproteins) system, a novel antibacterial target","volume":"51","author":"Ito","year":"2007","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.drudis.2026.104768_b0330","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1080\/22221751.2020.1754133","article-title":"Colistin and its role in the era of antibiotic resistance: an extended review (2000\u20132019)","volume":"9","author":"El-Sayed Ahmed","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.drudis.2026.104768_b0335","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.3390\/ijms26168103","article-title":"Antimicrobial peptides of the cathelicidin family: focus on LL-37 and its modifications","volume":"26","author":"Voronko","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104768_b0340","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3390\/antibiotics13090794","article-title":"Antimicrobial peptides and their biomedical applications: a review","volume":"13","author":"Min","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.drudis.2026.104768_b0345","doi-asserted-by":"crossref","DOI":"10.1128\/aem.02115-24","article-title":"Antimicrobial peptides: from discovery to developmental applications","volume":"91","author":"Zhang","year":"2025","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0350","article-title":"Advances and perspectives for antimicrobial peptide and combinatory therapies","volume":"10","author":"Santos","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.drudis.2026.104768_b0355","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1528583","article-title":"Unlocking the power of antimicrobial peptides: advances in production, optimization, and therapeutics","volume":"15","author":"Sadeeq","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0360","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.3390\/molecules30153070","article-title":"Current status of the application of antimicrobial peptides and their conjugated derivatives","volume":"30","author":"Del Olmo","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2026.104768_b0365","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41522-023-00427-y","article-title":"Strategy to combat biofilms: a focus on biofilm dispersal enzymes","volume":"9","author":"Wang","year":"2023","journal-title":"npj Biofilms Microbiomes"},{"key":"10.1016\/j.drudis.2026.104768_b0370","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3390\/microorganisms11061614","article-title":"Microbial biofilm: a review on formation, infection, antibiotic resistance, control measures, and innovative treatment","volume":"11","author":"Sharma","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.drudis.2026.104768_b0375","article-title":"Polymyxins: recent advances and challenges","volume":"15","author":"Yang","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2026.104768_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2024.127822","article-title":"Antimicrobial peptides: opportunities and challenges in overcoming resistance","volume":"286","author":"Bucataru","year":"2024","journal-title":"Microbiol Res"},{"key":"10.1016\/j.drudis.2026.104768_b0385","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/cts.12792","article-title":"Pharmacodynamic effects of topical omiganan in patients with mild to moderate atopic dermatitis in a randomized, placebo-controlled, phase II trial","volume":"13","author":"Niemeyer-Van der Kolk","year":"2020","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.drudis.2026.104768_b0390","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.616979","article-title":"Review: lessons learned from clinical trials using antimicrobial peptides (AMPs)","volume":"12","author":"Dijksteel","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0395","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1390765","article-title":"Synergistic action of antimicrobial peptides and antibiotics: current understanding and future directions","volume":"15","author":"Taheri-Araghi","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0400","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1021\/acsinfecdis.4c00702","article-title":"Advantages and challenges of using antimicrobial peptides in synergism with antibiotics for treating multidrug-resistant bacteria","volume":"11","author":"Gon\u00e7alves","year":"2025","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.drudis.2026.104768_b0405","doi-asserted-by":"crossref","first-page":"13535","DOI":"10.1039\/D4RA00631C","article-title":"Nanoparticles incorporated hydrogels for delivery of antimicrobial agents: developments and trends","volume":"14","author":"Ahmad","year":"2024","journal-title":"RSC Adv"},{"key":"10.1016\/j.drudis.2026.104768_b0410","doi-asserted-by":"crossref","first-page":"333","DOI":"10.24171\/j.phrp.2022.0323","article-title":"Strategies to combat Gram-negative bacterial resistance to conventional antibacterial drugs: a review","volume":"14","author":"Bhowmik","year":"2023","journal-title":"Osong Public Health Res Perspect"},{"key":"10.1016\/j.drudis.2026.104768_b0415","doi-asserted-by":"crossref","DOI":"10.1172\/JCI187996","article-title":"Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches","volume":"135","author":"Kim","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.drudis.2026.104768_b0420","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3390\/pathogens13100896","article-title":"Phage-based therapy in combination with antibiotics: a promising alternative against multidrug-resistant Gram-negative pathogens","volume":"13","author":"Anastassopoulou","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.drudis.2026.104768_b0425","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/ciy947","article-title":"A systematic and critical review of bacteriophage therapy against multidrug-resistant ESKAPE organisms in humans","volume":"69","author":"El Haddad","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.drudis.2026.104768_b0430","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/MMBR.67.4.593-656.2003","article-title":"Molecular basis of bacterial outer membrane permeability revisited","volume":"67","author":"Nikaido","year":"2003","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.drudis.2026.104768_b0435","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1021\/acsbiomaterials.4c02029","article-title":"Exploring the antimicrobial potential of LL-37 derivatives: recent developments and challenges","volume":"11","author":"Yuan","year":"2025","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.drudis.2026.104768_b0440","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02726-21","article-title":"Ceragenins and antimicrobial peptides kill bacteria through distinct mechanisms","volume":"13","author":"Mitchell","year":"2022","journal-title":"MBio"},{"key":"10.1016\/j.drudis.2026.104768_b0445","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1021\/acsmedchemlett.3c00460","article-title":"Development of novel membrane disrupting lipoguanidine compounds sensitizing Gram-negative bacteria to antibiotics","volume":"15","author":"Kim","year":"2024","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.drudis.2026.104768_b0450","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00753-24","article-title":"IMT-P8 potentiates Gram-positive specific antibiotics in intrinsically resistant Gram-negative bacteria","volume":"68","author":"Singh","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.drudis.2026.104768_b0455","doi-asserted-by":"crossref","first-page":"16162","DOI":"10.1038\/nmicrobiol.2016.162","article-title":"Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers","volume":"1","author":"Lam","year":"2016","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0460","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.3390\/molecules29112492","article-title":"Recent advances in amphipathic peptidomimetics as antimicrobial agents to combat drug resistance","volume":"29","author":"Su","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2026.104768_b0470","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nm.4465","article-title":"The role of vaccines in preventing bacterial antimicrobial resistance","volume":"24","author":"Jansen","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.drudis.2026.104768_b0475","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.vaccine.2009.01.072","article-title":"Genome-based approaches to develop vaccines against bacterial pathogens","volume":"27","author":"Serruto","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.drudis.2026.104768_b0480","doi-asserted-by":"crossref","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","article-title":"The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens","volume":"30","author":"Serruto","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.drudis.2026.104768_b0485","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s10096-017-3033-5","article-title":"Streptococcus pneumoniae antimicrobial resistance decreased in the Helsinki Metropolitan Area after routine 10-valent pneumococcal conjugate vaccination of infants in Finland","volume":"36","author":"Sihvonen","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.drudis.2026.104768_b0490","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1097\/00006454-199809001-00015","article-title":"Haemophilus influenzae disease in children in India: a hospital perspective","volume":"17","author":"John","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.drudis.2026.104768_b0495","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/fpd.2010.0730","article-title":"Impact of antibiotic use in adult dairy cows on antimicrobial resistance of veterinary and human pathogens: a comprehensive review","volume":"8","author":"Oliver","year":"2011","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.drudis.2026.104768_b0500","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41579-020-00506-3","article-title":"The role of vaccines in combatting antimicrobial resistance","volume":"19","author":"Micoli","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0505","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3389\/fmicb.2018.01009","article-title":"Targeting Clostridium difficile surface components to develop immunotherapeutic strategies against Clostridium difficile infection","volume":"9","author":"P\u00e9chin\u00e9","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.drudis.2026.104768_b0510","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/21645515.2020.1770034","article-title":"Optimization and qualification of an assay that demonstrates that a FimH vaccine induces functional antibody responses in women with histories of urinary tract infections","volume":"17","author":"Starks","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.drudis.2026.104768_b0515","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4161\/hv.34414","article-title":"Efficacy profile of a bivalent S. aureus glycoconjugated vaccine in adults on hemodialysis: phase III randomized study","volume":"11","author":"Fattom","year":"2015","journal-title":"Hum Vaccin Immunother"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964462600173X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964462600173X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:20:18Z","timestamp":1790094018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135964462600173X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":102,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S135964462600173X"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104768","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outer membrane as a drug target for the treatment of GNB infections","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104768"}}